X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (110) 110
Publication (28) 28
Newspaper Article (7) 7
Book Review (3) 3
Magazine Article (3) 3
Book / eBook (1) 1
Paper (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (78) 78
humans (77) 77
female (60) 60
middle aged (57) 57
male (55) 55
aged (47) 47
adult (43) 43
hematology (38) 38
oncology (32) 32
treatment outcome (28) 28
aged, 80 and over (26) 26
abridged index medicus (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (25) 25
prognosis (18) 18
bortezomib (15) 15
multiple myeloma - drug therapy (14) 14
rituximab (13) 13
therapy (13) 13
recurrence (12) 12
survival (12) 12
survival analysis (12) 12
antineoplastic combined chemotherapy protocols - administration & dosage (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
cancer (11) 11
chemotherapy (11) 11
disease-free survival (11) 11
multiple myeloma (10) 10
multiple myeloma - therapy (10) 10
non-hodgkins-lymphoma (10) 10
thalidomide - administration & dosage (10) 10
antibodies, monoclonal, murine-derived (9) 9
article (9) 9
boronic acids - administration & dosage (9) 9
follow-up studies (9) 9
pyrazines - administration & dosage (9) 9
retrospective studies (9) 9
thalidomide - analogs & derivatives (9) 9
animals (8) 8
antineoplastic agents - therapeutic use (8) 8
chronic myelogenous leukemia (8) 8
cyclophosphamide - administration & dosage (8) 8
lymphoma, large b-cell, diffuse - drug therapy (8) 8
multiple myeloma - pathology (8) 8
multiple-myeloma (8) 8
survival rate (8) 8
waldenstrom macroglobulinemia - drug therapy (8) 8
cyclophosphamide - therapeutic use (7) 7
doxorubicin - administration & dosage (7) 7
multiple myeloma - immunology (7) 7
prednisone - administration & dosage (7) 7
risk factors (7) 7
transplantation (7) 7
transplantation, autologous (7) 7
vincristine - administration & dosage (7) 7
vincristine - therapeutic use (7) 7
boronic acids - adverse effects (6) 6
cells (6) 6
combined modality therapy (6) 6
dexamethasone - administration & dosage (6) 6
doxorubicin - therapeutic use (6) 6
elderly-patients (6) 6
immunohistochemistry (6) 6
incidence (6) 6
measurement error (6) 6
mice (6) 6
multiple myeloma - mortality (6) 6
prednisone - therapeutic use (6) 6
prospective studies (6) 6
pyrazines - adverse effects (6) 6
remission induction (6) 6
risk (6) 6
stem cell transplantation (6) 6
t-lymphocytes - immunology (6) 6
tumor cells, cultured (6) 6
2nd international workshop (5) 5
antibodies, monoclonal - administration & dosage (5) 5
bone-marrow transplantation (5) 5
care and treatment (5) 5
cohort studies (5) 5
consensus panel recommendations (5) 5
dexamethasone (5) 5
disease progression (5) 5
dose-response relationship, drug (5) 5
expression (5) 5
hematopoietic stem cell transplantation (5) 5
hemic and lymphatic diseases (5) 5
lenalidomide (5) 5
lymphoma, large b-cell, diffuse - diagnosis (5) 5
management (5) 5
multiple myeloma - metabolism (5) 5
original reports (5) 5
relapse (5) 5
stem-cell transplantation (5) 5
time factors (5) 5
trial (5) 5
versus-host disease (5) 5
adolescent (4) 4
age factors (4) 4
analysis (4) 4
antibodies, monoclonal, murine-derived - administration & dosage (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 04/2013, Volume 123, Issue 4, pp. 1542 - 1555
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 14, pp. 1311 - 1320
In this trial, 700 patients with myeloma were randomly assigned to receive RVD therapy (lenalidomide, bortezomib, and dexamethasone) with or without autologous... 
DIAGNOSED MULTIPLE-MYELOMA | MEDICINE, GENERAL & INTERNAL | PHASE-III | AUTOLOGOUS TRANSPLANTATION | DARATUMUMAB MONOTHERAPY | INITIAL TREATMENT | FOLLOW-UP | PREDNISONE PLUS THALIDOMIDE | RANDOMIZED CONTROLLED-TRIAL | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Induction Chemotherapy | Male | Transplantation, Autologous | Stem Cell Transplantation | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Adult | Female | Maintenance Chemotherapy | Thalidomide - adverse effects | Dexamethasone - administration & dosage | Lenalidomide | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Bortezomib - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bortezomib - adverse effects | Aged | Usage | Care and treatment | Bortezomib | Dexamethasone | Patient outcomes | Multiple myeloma | Transplantation of organs, tissues, etc | Dosage and administration | Autografts | Gastrointestinal tract diseases | Minimal residual disease | Stem cell transplantation | Peripheral neuropathy | Patients | Chemotherapy | Melphalan | Thromboembolism | Neutropenia | Index Medicus | Abridged Index Medicus | Life Sciences | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2013, Volume 31, Issue 33, pp. 4199 - 4206
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2014, Volume 32, Issue 27, pp. 3068 - 3074
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2009, Volume 27, Issue 21, pp. 3518 - 3525
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2009, Volume 27, Issue 34, pp. 5713 - 5719
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2010, Volume 107, Issue 11, pp. 5124 - 5129
Journal Article